About the Journal

Focus and Scope

Cermin Dunia Kedokteran (CDK) is a Medical Journal published since 1974 and affiliated with PT Kalbe Farma Tbk. CDK is intended to help accommodate scientific publications and help increase and disseminate knowledge related to the development of medical science, pharmacy, and public health.

Since 2010 CDK has collaborated with PB IDI (Executive Board of the Indonesian Doctors Association) to publish CME (Continuing Medical Education) texts with SKP for doctors. Currently, CDK also publishes articles with the SKP from Kemenkes for doctors.

CDK covers the disciplines of medicine, pharmacy, and health with several types of articles, namely:

1. Research
2. Literature review 
3. Case report 
4. Evidence-based case report (EBCR), systematic review

5. Other scientific articles

CDK has been registered and published with the International Standard Serial Number (ISSN):

- e-ISSN: 2503-2720
- p-ISSN: 0125-913X

Based on the SK Kemendikbudristek Nomor 152/E/KPT/2023, CDK has obtained Rank 4 (SINTA 4) for Scientific Journals.

Open Access Policy

Cermin Dunia Kedokteran as an open access journal adheres to the I4OC standard, using CC-BY-NC attribution, so articles in this journal are bound to the Creative Commons Attribution 4.0 International License. All articles are available on the internet, and are free of charge to all users immediately after publication. The journal provides direct open access to its contents in pdf format.

Publication Frequency

Cermin Dunia Kedokteran since 2010 (Volume 37), published 8 (eight) times per year.

Cermin Dunia Kedokteran since 2012 (Volume 39), published 12 (twelve) times every year.

Cermin Dunia Kedokteransince 2016 (Volume 43), regularly published 12 (twelve) times per year online at www.cdkjournal.com based on OJS.

Author Fees

Article Publication Process

In general, the process of submitting an article to CDK is as follows:
1. Initial screening (within 3 working days), including writing style, compliance with CDK writing guidelines, and similarity index.
2. Once the article meets the criteria, it will enter the review process by the editorial team.
At this stage, if necessary, the author can obtain a Letter of Confirmation stating that the manuscript is under review and planned for publication in the CDK journal.
3. The editorial team (editors) will send feedback to the author. The author will revise the article based on the review results (this can be done several times according to the editorial team's input).
4. Once the article is final, it will be scheduled for publication.

The estimated time for article publication is approximately 4-8 months after finalization (may be shorter or longer).

For further information, please contact the CDK secretariat via 021-42873888 ext. 2023 or cdk@kalbe.co.id.